These four tutorials will completely change how you draw eyes. Learn essential techniques for structure, proportions, shading, and expression that help bring eyes to life and make your drawings more ...

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

AI adoption has surged from 45% in the finance sector in 2022 to a projected 85% by 2025, with 60% of businesses already leveraging AI across multiple functions. This rapid integration of AI extends ...

A new pair of malicious Visual Studio Code extensions capable of harvesting screenshots, browser sessions and stored credentials has been discovered by cybersecurity researchers. The extensions, ...

Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression free survival (mPFS) compared to 11.0 months mPFS with pembrolizumab alone; study narrowly missed progression ...

The 2026 International Advanced Air Mobility Expo, to be held in July next year, is projected to attract up to 100,000 visitors, expanding its influence both at home and abroad, according to the event ...

NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today ...

Disney+ is set to kick off he 2025/26 UEFA Women’s Champions League season by streaming the League Phase draw live on September 19th. As part of their existing subscription, fans across Europe can ...

Privacy-focused consumer tech company DuckDuckGo launched a subscription plan last year that bundled a VPN service, personal information removal, and identity theft ...

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT) today announces topline results from the pivotal Phase 3 trial of its investigational, immune-modulatory, off-the-shelf ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the transformative ...